1-6 of 6
Walter Feremans, MD
Close
Sort by
Journal Articles

Long Term Efficacy of Rituximab in B-Cell Post Transplantation Lymphoproliferative Disorders (B-PTLD): Update of the Multicenter, Open Label, Phase II Trial (M39037 TRIAL).

Sylvain Choquet, MD, Raoul Herbrecht, MD, Anne-marie Stoppa, MD, Peter Vandenberghe, MD, Walter Feremans, MD, Franck Morschhauser, MD, Gilles Andre Salles, MD, Arnaud Jaccard, MD, Thierry Lamy, MD, Yves Lebranchu, MD, Philippe Offner, MD, Eric Oksenhendler, MD, Martine Raphael, MD, Veronique Leblond, MD, Noel-Jean Milpied, MD
Journal: Blood
Blood (2006) 108 (11): 2764.
https://doi.org/10.1182/blood.V108.11.2764.2764
Published: 2006
Journal Articles

Dexamethasone Versus Methyl-Prednisolone in Induction Therapy for Adult Acute Lymphoblastic (ALL) and Non-Hodgkin Lymphoma (NHL) Patients ≤ 60 Yrs Old: Final Results of the Eortc All-4 Phase III Trial.

Boris Labar, MD, PhD, Stefan Suciu, PhD, Petra Muus, MD, Roelof Willemze, MD, PhD, Jean-Pierre Marie, MD, Georges Fillet, MD, Zwi Berneman, MD, Branimir Jaksic, MDPhD, Walter Feremans, MD, Dominique Bron, MD, Henry Sinnige, MD, Martin Mistrik, MD, G. Vreugdenhil, MD, Robrecht De Bock, MD, Damir Nemet, MD, Caroline Gilotay, Theo de Witte, MDPhD, Sergio Amadori, MD
Journal: Blood
Blood (2005) 106 (11): 1834.
https://doi.org/10.1182/blood.V106.11.1834.1834
Published: 2005
Journal Articles

Immunological Recovery after Nonmyeloablative Transplant: A Prospective Study of 24 Patients Treated in a Single Center.

Dominique Bron, MD PhD, Van Hyunh, MD, Virginie Dewilde, MD, Jalil Bennani, MD, Philippe Lewalle, MD, Phuong Huynh, MD, Rita Leroy, Patrick Crombez, Louisette Debusscher, MD, Walter Feremans, MD, PhD, Michel Bernier, MD, Philippe Martiat, MD
Journal: Blood
Blood (2004) 104 (11): 5044.
https://doi.org/10.1182/blood.V104.11.5044.5044
Published: 2004
Journal Articles

Identical-Twin Transplants for B-Cell Chronic Lymphocytic Leukemia (B-CLL).

Steven Pavletic, MD, Guimei Zhou, MD, Kathleen Sobocinski, MS, Kristine Doney, MD, John DiPersio, MD, Walter Feremans, MD, Letizia Foroni, MD, H. Grant Prentice, MBBS, Charles LeMaistre, MD, Giuseppe Bandini, MD, Augustin Ferrant, MD, Niels Jacobsen, MD, Issa Khouri, MD, Robert Peter Gale, MD, Sergio Giralt, MD, Emilio Montserrat, MD, John Chan, MD, Christopher Bredeson, MD
Journal: Blood
Blood (2004) 104 (11): 3330.
https://doi.org/10.1182/blood.V104.11.3330.3330
Published: 2004
Journal Articles

Long Term Follow-Up Shows No Clinical Benefit for CD34 + Selection of Autologous Transplants Following Myeloablative Therapy in Patients with Newly Diagnosed Myeloma : An EBMT Phase III Randomized Study.

Jean-Henri Bourhis, MD, Yasmina Bouko, MD, Serge Koscielny, PhD, Hildegard Greinix, MD, Gunter Derigs, MD, Gilles Salles, MD, Walter Feremans, MD, Marleen Bakkus, PhD, Jane Apperley, MD, Diana Samson, MD, Bo Bjorkstrand, MD, Dietger Niederwieser, MD, Gosta Gahrton, MD, Jose-Luis Pico, MD, Hartmut Goldschmidt, MD
Journal: Blood
Blood (2004) 104 (11): 921.
https://doi.org/10.1182/blood.V104.11.921.921
Published: 2004
Journal Articles

Trisenox® (arsenic trioxide) in Patients with Myelodysplastic Syndromes (MDS): Preliminary Results of a Phase I/II Study.

Norbert Vey, MD, Francois Dreyfus, MD, Agnes Guerci, MD, Pierre Fenaux, MD, Herve Dombret, MD, Alan K. Burnett, MD, Andre Bosly, MD, Walter Feremans, MD, David T. Bowen, MD, Marja Heiskala, MD
Journal: Blood
Blood (2004) 104 (11): 1433.
https://doi.org/10.1182/blood.V104.11.1433.1433
Published: 2004